Olivier Baldesi1, Sébastien Bailly2, Stéphane Ruckly2, Alain Lepape3, François L'Heriteau4, Martine Aupee5, Sandrine Boussat6, Caroline Bervas7, Anais Machut8, Anne Berger-Carbonne9, Anne Savey10, Jean François Timsit11. 1. Centre Hospitalier Intercommunal Aix-Pertuis, Aix en Provence, France. 2. UMR 1137 - IAME Team 5 - DeSCID: Decision SCiences in Infectious Diseases, Control and Care INSERM Université Paris Diderot, Sorbonne Paris Cité, F-75018 Paris, France. 3. Unité de recherche clinique Soins critiques, Lyon, France. 4. CCLIN Paris-Nord - APHP, Paris, France. 5. CCLIN Ouest - CHU Rennes, Rennes, France. 6. CCLIN Est - CHU Nancy, Nancy, France. 7. CCLIN Sud-Ouest - CHU Bordeaux, Bordeaux, France. 8. CCLIN Sud-Est - HCL, Lyon, France. 9. Unité Infections associées aux soins et Résistance aux Antibiotiques, Direction Maladies Infectieuses - Santé publique France - Saint Maurice, Paris, France. 10. CCLIN Sud-Est - HCL - CNRS UMR 5558 Université de Lyon 1, Lyon, France. 11. UMR 1137 - IAME Team 5 - DeSCID: Decision SCiences in Infectious Diseases, Control and Care INSERM Université Paris Diderot, Sorbonne Paris Cité, F-75018 Paris, France; AP-HP - Medical and Infectious Diseases ICU, Université Paris Diderot/Hôpital Bichat, Paris, France. Electronic address: Jean-francois.timsit@bch.aphp.fr.
Abstract
OBJECTIVE: Candidaemia is a life-threatening infectious disease, associated with septic shock, multiple organ failure, and a high mortality rate. In France, reported data on the incidence of ICU-acquired candidaemia and the causative Candida species are scarce. The objective of this study was to determine temporal trends in epidemiology and risk factors of intensive care unit-acquired candidaemia (ICU-Cand) and ICU mortality among a very large population of ICU patients. METHOD: Demographics, patient risk factors, invasive device exposure and nosocomial infection in ICU patient were collected from 2004 to 2013 in a national network of 213 ICUs: REA-RAISIN. Incidence and risk factors for candidaemia and ICU mortality were assessed. RESULTS: Out of 246,459 ICU patients, 851 developed an ICU-cand, representing 0.3 per 1000 patients-days. The incidence rose sharply over time. Candida albicans was the main species. The overall and ICU mortality was 52.4% in ICU-cand patients. The main risk factors of ICU-cand were length of stay, severity of illness and antimicrobial therapy at ICU admission, immune status and use of invasive procedure. ICU-cand was an independent risk factor of mortality (OR: 1.53; 95%CI [1.40-1.70]); in a sub-group analysis, independent effects on mortality were observed with C. albicans (OR: 1.45 [1.23-1.71]), Candida tropicalis (OR: 2.11 [1.31-3.39]) and "other" Candida species (OR: 1.64 [1.09-2.45]). CONCLUSION: ICU candidaemia ranked sixth among bloodstream infections, and its average annual incidence was 0.3 per 1000 patients days. Despite of new therapy and international recommendation, the incidence rose sharply during the study period, and ICU mortality remained high.
OBJECTIVE: Candidaemia is a life-threatening infectious disease, associated with septic shock, multiple organ failure, and a high mortality rate. In France, reported data on the incidence of ICU-acquired candidaemia and the causative Candida species are scarce. The objective of this study was to determine temporal trends in epidemiology and risk factors of intensive care unit-acquired candidaemia (ICU-Cand) and ICU mortality among a very large population of ICU patients. METHOD: Demographics, patient risk factors, invasive device exposure and nosocomial infection in ICU patient were collected from 2004 to 2013 in a national network of 213 ICUs: REA-RAISIN. Incidence and risk factors for candidaemia and ICU mortality were assessed. RESULTS: Out of 246,459 ICU patients, 851 developed an ICU-cand, representing 0.3 per 1000 patients-days. The incidence rose sharply over time. Candida albicans was the main species. The overall and ICU mortality was 52.4% in ICU-cand patients. The main risk factors of ICU-cand were length of stay, severity of illness and antimicrobial therapy at ICU admission, immune status and use of invasive procedure. ICU-cand was an independent risk factor of mortality (OR: 1.53; 95%CI [1.40-1.70]); in a sub-group analysis, independent effects on mortality were observed with C. albicans (OR: 1.45 [1.23-1.71]), Candida tropicalis (OR: 2.11 [1.31-3.39]) and "other" Candida species (OR: 1.64 [1.09-2.45]). CONCLUSION: ICU candidaemia ranked sixth among bloodstream infections, and its average annual incidence was 0.3 per 1000 patients days. Despite of new therapy and international recommendation, the incidence rose sharply during the study period, and ICU mortality remained high.
Authors: Ignacio Martin-Loeches; Massimo Antonelli; Manuel Cuenca-Estrella; George Dimopoulos; Sharon Einav; Jan J De Waele; Jose Garnacho-Montero; Souha S Kanj; Flavia R Machado; Philippe Montravers; Yasser Sakr; Maurizio Sanguinetti; Jean-Francois Timsit; Matteo Bassetti Journal: Intensive Care Med Date: 2019-03-25 Impact factor: 17.440
Authors: Daniele Roberto Giacobbe; Antonio Salsano; Filippo Del Puente; Ambra Miette; Antonio Vena; Silvia Corcione; Michele Bartoletti; Alessandra Mularoni; Alberto Enrico Maraolo; Maddalena Peghin; Alessia Carnelutti; Angela Raffaella Losito; Francesca Raffaelli; Ivan Gentile; Beatrice Maccari; Stefano Frisone; Renato Pascale; Elisa Mikus; Alice Annalisa Medaglia; Elena Conoscenti; Davide Ricci; Tommaso Lupia; Marco Comaschi; Maddalena Giannella; Mario Tumbarello; Francesco Giuseppe De Rosa; Valerio Del Bono; Malgorzata Mikulska; Francesco Santini; Matteo Bassetti Journal: Open Forum Infect Dis Date: 2020-06-19 Impact factor: 3.835
Authors: Matteo Bassetti; Daniele R Giacobbe; Antonio Vena; Cecilia Trucchi; Filippo Ansaldi; Massimo Antonelli; Vaclava Adamkova; Cristiano Alicino; Maria-Panagiota Almyroudi; Enora Atchade; Anna M Azzini; Novella Carannante; Alessia Carnelutti; Silvia Corcione; Andrea Cortegiani; George Dimopoulos; Simon Dubler; José L García-Garmendia; Massimo Girardis; Oliver A Cornely; Stefano Ianniruberto; Bart Jan Kullberg; Katrien Lagrou; Clement Le Bihan; Roberto Luzzati; Manu L N G Malbrain; Maria Merelli; Ana J Marques; Ignacio Martin-Loeches; Alessio Mesini; José-Artur Paiva; Maddalena Peghin; Santi Maurizio Raineri; Riina Rautemaa-Richardson; Jeroen Schouten; Pierluigi Brugnaro; Herbert Spapen; Polychronis Tasioudis; Jean-François Timsit; Valentino Tisa; Mario Tumbarello; Charlotte H S B van den Berg; Benoit Veber; Mario Venditti; Guillaume Voiriot; Joost Wauters; Philippe Montravers Journal: Crit Care Date: 2019-06-14 Impact factor: 9.097
Authors: Emily E Ricotta; Yi Ling Lai; Ahmed Babiker; Jeffrey R Strich; Sameer S Kadri; Michail S Lionakis; D Rebecca Prevots; Jennifer Adjemian Journal: J Infect Dis Date: 2021-04-08 Impact factor: 5.226